vs
百利高（PRGO）与Trade Desk (The)（TTD）财务数据对比。点击上方公司名可切换其他公司
百利高的季度营收约是Trade Desk (The)的1.3倍（$1.1B vs $846.8M），Trade Desk (The)净利率更高（22.1% vs -127.8%，领先149.9%），Trade Desk (The)同比增速更快（14.3% vs -2.5%），Trade Desk (The)自由现金流更多（$285.3M vs $148.6M），过去两年Trade Desk (The)的营收复合增速更高（31.3% vs 1.3%）
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
The Trade Desk是来自美国的跨国科技企业，专注于实时程序化营销自动化领域的技术、产品与服务研发，可实现面向用户的个性化数字内容分发，为全球广告营销行业客户提供专业解决方案。
PRGO vs TTD — 直观对比
营收规模更大
PRGO
是对方的1.3倍
$846.8M
营收增速更快
TTD
高出16.8%
-2.5%
净利率更高
TTD
高出149.9%
-127.8%
自由现金流更多
TTD
多$136.7M
$148.6M
两年增速更快
TTD
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $846.8M |
| 净利润 | $-1.4B | $186.9M |
| 毛利率 | 32.6% | 80.7% |
| 营业利润率 | -116.0% | 30.3% |
| 净利率 | -127.8% | 22.1% |
| 营收同比 | -2.5% | 14.3% |
| 净利润同比 | -3093.9% | 2.6% |
| 每股收益（稀释后） | $-10.23 | $0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRGOTTD
| Q4 25 | $1.1B | $846.8M | ||
| Q3 25 | $1.0B | $739.4M | ||
| Q2 25 | $1.1B | $694.0M | ||
| Q1 25 | $1.0B | $616.0M | ||
| Q4 24 | $1.1B | $741.0M | ||
| Q3 24 | $1.1B | $628.0M | ||
| Q2 24 | $1.1B | $584.5M | ||
| Q1 24 | $1.1B | $491.3M |
净利润PRGOTTD
| Q4 25 | $-1.4B | $186.9M | ||
| Q3 25 | $7.5M | $115.5M | ||
| Q2 25 | $-8.4M | $90.1M | ||
| Q1 25 | $-6.4M | $50.7M | ||
| Q4 24 | $-44.4M | $182.2M | ||
| Q3 24 | $-21.0M | $94.2M | ||
| Q2 24 | $-108.4M | $85.0M | ||
| Q1 24 | $2.0M | $31.7M |
毛利率PRGOTTD
| Q4 25 | 32.6% | 80.7% | ||
| Q3 25 | 36.1% | 78.1% | ||
| Q2 25 | 34.4% | 78.2% | ||
| Q1 25 | 37.6% | 76.8% | ||
| Q4 24 | 33.9% | 81.7% | ||
| Q3 24 | 37.2% | 80.5% | ||
| Q2 24 | 37.0% | 81.1% | ||
| Q1 24 | 33.1% | 78.9% |
营业利润率PRGOTTD
| Q4 25 | -116.0% | 30.3% | ||
| Q3 25 | 7.0% | 21.8% | ||
| Q2 25 | 4.3% | 16.8% | ||
| Q1 25 | 4.5% | 8.8% | ||
| Q4 24 | 10.0% | 26.4% | ||
| Q3 24 | 7.4% | 17.3% | ||
| Q2 24 | -2.5% | 16.2% | ||
| Q1 24 | -5.1% | 5.8% |
净利率PRGOTTD
| Q4 25 | -127.8% | 22.1% | ||
| Q3 25 | 0.7% | 15.6% | ||
| Q2 25 | -0.8% | 13.0% | ||
| Q1 25 | -0.6% | 8.2% | ||
| Q4 24 | -3.9% | 24.6% | ||
| Q3 24 | -1.9% | 15.0% | ||
| Q2 24 | -10.2% | 14.5% | ||
| Q1 24 | 0.2% | 6.4% |
每股收益（稀释后）PRGOTTD
| Q4 25 | $-10.23 | $0.39 | ||
| Q3 25 | $0.05 | $0.23 | ||
| Q2 25 | $-0.06 | $0.18 | ||
| Q1 25 | $-0.05 | $0.10 | ||
| Q4 24 | $-0.32 | $0.36 | ||
| Q3 24 | $-0.15 | $0.19 | ||
| Q2 24 | $-0.79 | $0.17 | ||
| Q1 24 | $0.01 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.3B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.9B | $2.5B |
| 总资产 | $8.5B | $6.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRGOTTD
| Q4 25 | — | $1.3B | ||
| Q3 25 | $432.1M | $1.4B | ||
| Q2 25 | $454.2M | $1.7B | ||
| Q1 25 | $409.9M | $1.7B | ||
| Q4 24 | $558.8M | $1.9B | ||
| Q3 24 | $1.5B | $1.7B | ||
| Q2 24 | $542.8M | $1.5B | ||
| Q1 24 | $658.5M | $1.4B |
股东权益PRGOTTD
| Q4 25 | $2.9B | $2.5B | ||
| Q3 25 | $4.4B | $2.6B | ||
| Q2 25 | $4.5B | $2.7B | ||
| Q1 25 | $4.4B | $2.7B | ||
| Q4 24 | $4.3B | $2.9B | ||
| Q3 24 | $4.6B | $2.6B | ||
| Q2 24 | $4.5B | $2.4B | ||
| Q1 24 | $4.7B | $2.2B |
总资产PRGOTTD
| Q4 25 | $8.5B | $6.2B | ||
| Q3 25 | $10.1B | $5.9B | ||
| Q2 25 | $10.1B | $6.0B | ||
| Q1 25 | $9.8B | $5.7B | ||
| Q4 24 | $9.6B | $6.1B | ||
| Q3 24 | $11.2B | $5.5B | ||
| Q2 24 | $10.4B | $5.2B | ||
| Q1 24 | $10.6B | $4.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $175.4M | $311.6M |
| 自由现金流经营现金流 - 资本支出 | $148.6M | $285.3M |
| 自由现金流率自由现金流/营收 | 13.4% | 33.7% |
| 资本支出强度资本支出/营收 | 2.4% | 3.1% |
| 现金转化率经营现金流/净利润 | — | 1.67× |
| 过去12个月自由现金流最近4个季度 | $145.1M | $795.7M |
8季度趋势，按日历期对齐
经营现金流PRGOTTD
| Q4 25 | $175.4M | $311.6M | ||
| Q3 25 | $51.7M | $224.7M | ||
| Q2 25 | $75.9M | $165.0M | ||
| Q1 25 | $-64.5M | $291.4M | ||
| Q4 24 | $312.6M | $199.4M | ||
| Q3 24 | $42.2M | $273.3M | ||
| Q2 24 | $9.5M | $81.3M | ||
| Q1 24 | $-1.4M | $185.5M |
自由现金流PRGOTTD
| Q4 25 | $148.6M | $285.3M | ||
| Q3 25 | $29.8M | $158.3M | ||
| Q2 25 | $56.7M | $119.8M | ||
| Q1 25 | $-90.0M | $232.3M | ||
| Q4 24 | $274.9M | $179.2M | ||
| Q3 24 | $15.1M | $224.6M | ||
| Q2 24 | $-18.9M | $59.1M | ||
| Q1 24 | $-26.5M | $178.2M |
自由现金流率PRGOTTD
| Q4 25 | 13.4% | 33.7% | ||
| Q3 25 | 2.9% | 21.4% | ||
| Q2 25 | 5.4% | 17.3% | ||
| Q1 25 | -8.6% | 37.7% | ||
| Q4 24 | 24.2% | 24.2% | ||
| Q3 24 | 1.4% | 35.8% | ||
| Q2 24 | -1.8% | 10.1% | ||
| Q1 24 | -2.4% | 36.3% |
资本支出强度PRGOTTD
| Q4 25 | 2.4% | 3.1% | ||
| Q3 25 | 2.1% | 9.0% | ||
| Q2 25 | 1.8% | 6.5% | ||
| Q1 25 | 2.4% | 9.6% | ||
| Q4 24 | 3.3% | 2.7% | ||
| Q3 24 | 2.5% | 7.8% | ||
| Q2 24 | 2.7% | 3.8% | ||
| Q1 24 | 2.3% | 1.5% |
现金转化率PRGOTTD
| Q4 25 | — | 1.67× | ||
| Q3 25 | 6.89× | 1.94× | ||
| Q2 25 | — | 1.83× | ||
| Q1 25 | — | 5.75× | ||
| Q4 24 | — | 1.09× | ||
| Q3 24 | — | 2.90× | ||
| Q2 24 | — | 0.96× | ||
| Q1 24 | -0.70× | 5.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
TTD
| Other | $427.2M | 50% |
| Non Us | $419.6M | 50% |
